Literature DB >> 33392026

Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an 18F-AV-45 study.

Min Wang1,2, Zhuangzhi Yan2, Huiwei Zhang3, Jiaying Lu3, Ling Li3, Jintai Yu4, Jian Wang4, Hiroshi Matsuda5, Chuantao Zuo3, Jiehui Jiang1,2.   

Abstract

BACKGROUND: Positron emission tomography (PET) with the radiotracer florbetapir (18F-AV-45) allows the pathophysiology of Alzheimer's disease (AD) to be tracked in vivo. The semi-quantification of amyloid-beta (Aβ) has been extensively evaluated with the standardized uptake value ratio (SUVR) but is susceptible to disturbance from the candidate reference region and the partial volume effect (PVE). In the present study, we applied the parametric estimation of reference signal intensity (PERSI) method to 18F-AV-45 PET images for intensity normalization.
METHODS: We enrolled 479 people with 18F-AV-45 images from the Alzheimer's Disease Neuroimaging Initiative database: 261 healthy controls (HCs), 102 patients with mild cognitive impairment (MCI), and 116 AD patients. We used white matter post-processed by PERSI (PERSI-WM) as the reference region and compared our proposed method with the traditional method for semi-quantification. SUVRs were calculated for eight regions of interest: the frontal lobe, the parietal lobe, the temporal lobe, the occipital lobe, the anterior cingulate cortex, the posterior cingulate cortex, the precuneus, and the global cortex. The SUVRs derived from PERSI-WM and other reference regions were evaluated by effect size and receiver-operator characteristic curve analyses.
RESULTS: The SUVRs derived from PERSI-WM showed significantly higher trace retention in the frontal, parietal, temporal, and occipital lobes, as well as in the anterior cingulate, posterior cingulate, precuneus, and global cortex in the AD Aβ-positive (+) group (mean: +43.3%±5.4%, P<0.01) and MCI Aβ+ group (mean: +29.6%±5.3%, P<0.01). For the global cortex, PERSI-WM had the greatest Cohen's d effect size compared with the HC Aβ-negative (-) group (AD Aβ+ and MCI Aβ+: 3.02, AD Aβ+: 3.56, MCI Aβ+: 2.34), and the highest area under the curve (AUC) between the HC Aβ- and AD Aβ+ groups (AUC: 0.983, 95% confidence interval: 0.978-0.998).
CONCLUSIONS: PERSI-WM could mitigate the influence of PVE and improve the semi-quantification of 18F-AV-45 images; therefore, it could be used for large-scale clinical application in the nuclear medicine domain. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease (AD); Amyloid-beta (Aβ); florbetapir positron emission tomography; parametric estimation of reference signal intensity (PERSI); quantification; standardized uptake value ratio (SUVR)

Year:  2021        PMID: 33392026      PMCID: PMC7719939          DOI: 10.21037/qims-20-110

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  42 in total

1.  Correction for partial volume effects in PET: principle and validation.

Authors:  O G Rousset; Y Ma; A C Evans
Journal:  J Nucl Med       Date:  1998-05       Impact factor: 10.057

2.  Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.

Authors:  Koon-Pong Wong; Mirwais Wardak; Weber Shao; Magnus Dahlbom; Vladimir Kepe; Jie Liu; Nagichettiar Satyamurthy; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

3.  Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.

Authors:  Susan M Landau; Christopher Breault; Abhinay D Joshi; Michael Pontecorvo; Chester A Mathis; William J Jagust; Mark A Mintun
Journal:  J Nucl Med       Date:  2012-11-19       Impact factor: 10.057

4.  In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

Authors:  Hanna Cho; Jae Yong Choi; Mi Song Hwang; You Jin Kim; Hye Mi Lee; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Myung Sik Lee; Chul Hyoung Lyoo
Journal:  Ann Neurol       Date:  2016-07-08       Impact factor: 10.422

5.  Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.

Authors:  Adam S Fleisher; Kewei Chen; Xiaofen Liu; Napatkamon Ayutyanont; Auttawut Roontiva; Pradeep Thiyyagura; Hillary Protas; Abhinay D Joshi; Marwan Sabbagh; Carl H Sadowsky; Reisa A Sperling; Christopher M Clark; Mark A Mintun; Michael J Pontecorvo; R Edward Coleman; P M Doraiswamy; Keith A Johnson; Alan P Carpenter; Daniel M Skovronsky; Eric M Reiman
Journal:  Neurobiol Aging       Date:  2012-05-24       Impact factor: 4.673

6.  Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Authors:  Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

7.  PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.

Authors:  Georg A Becker; Masanori Ichise; Henryk Barthel; Julia Luthardt; Marianne Patt; Anita Seese; Marcus Schultze-Mosgau; Beate Rohde; Hermann-Josef Gertz; Cornelia Reininger; Osama Sabri
Journal:  J Nucl Med       Date:  2013-03-07       Impact factor: 10.057

8.  Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.

Authors:  Keith A Johnson; Reisa A Sperling; Christopher M Gidicsin; Jeremy S Carmasin; Jacqueline E Maye; Ralph E Coleman; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Adam S Fleisher; P Murali Doraiswamy; Alan P Carpenter; Christopher M Clark; Abhinay D Joshi; Ming Lu; Michel Grundman; Mark A Mintun; Michel J Pontecorvo; Daniel M Skovronsky
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

9.  Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.

Authors:  Kun-Ju Lin; Ing-Tsung Hsiao; Jung-Lung Hsu; Chin-Chang Huang; Kuo-Lun Huang; Chia-Ju Hsieh; Shiaw-Pyng Wey; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-22       Impact factor: 9.236

10.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

View more
  1 in total

1.  Tracer-specific reference tissues selection improves detection of 18 F-FDG, 18 F-florbetapir, and 18 F-flortaucipir PET SUVR changes in Alzheimer's disease.

Authors:  Yanxiao Li; Yee Ling Ng; Manish D Paranjpe; Qi Ge; Fengyun Gu; Panlong Li; Shaozhen Yan; Jie Lu; Xiuying Wang; Yun Zhou
Journal:  Hum Brain Mapp       Date:  2022-02-15       Impact factor: 5.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.